Patents by Inventor Ulrich Dirnagl

Ulrich Dirnagl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ERYTHROPOIETIN VARIANTS
    Publication number: 20190106470
    Abstract: The present invention relates to novel endogenous variants of erythropoietin (EPO) and their use for treatment or prevention of a condition associated with tissue damage due to cell death (apoptosis, necrosis) and inflammation, in particular for neuroprotection, e.g. treatment of acute (for example stroke) and chronic disease (for example ALS) of the nervous system.
    Type: Application
    Filed: June 4, 2018
    Publication date: April 11, 2019
    Applicant: CHARITE UNIVERSITAETSMEDIZEN-BERLIN
    Inventors: Andreas MEISEL, Josef PRILLER, Christel BONNAS, Ulrich DIRNAGL
  • Erythropoietin variants
    Patent number: 9988427
    Abstract: The present invention relates to novel endogenous variants of erythropoietin (EPO) and their use for treatment or prevention of a condition associated with tissue damage due to cell death (apoptosis, necrosis) and inflammation, in particular for neuroprotection, e.g. treatment of acute (for example stroke) and chronic disease (for example ALS) of the nervous system.
    Type: Grant
    Filed: December 15, 2008
    Date of Patent: June 5, 2018
    Assignee: CHARITE UNIVERSITAETSMEDIZEN-BERLIN
    Inventors: Andreas Meisel, Josef Priller, Christel Bonnas, Ulrich Dirnagl
  • Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
    Patent number: 8673934
    Abstract: The invention refers to agents for the preventive therapy after acute stroke, in particular having the aim to prevent infections after stroke. The agents inventively employed in pharmaceutical preparations are anti-infective agents and/or immunomodulating agents, e.g. cytokines and/or inhibitors of the SNS.
    Type: Grant
    Filed: March 5, 2003
    Date of Patent: March 18, 2014
    Inventors: Andreas Meisel, Konstantin Prass, Christian Meisel, Elke Halle, Ulrich Dirnagl, Hans Dieter Volk
  • ERYTHROPOIETIN VARIANTS
    Publication number: 20110008363
    Abstract: The present invention relates to novel endogenous variants of erythropoietin (EPO) and their use for treatment or prevention of a condition associated with tissue damage due to cell death (apoptosis, necrosis) and inflammation, in particular for neuroprotection, e.g. treatment of acute (for example stroke) and chronic disease (for example ALS) of the nervous system.
    Type: Application
    Filed: December 15, 2008
    Publication date: January 13, 2011
    Inventors: Andreas Meisel, Josef Priller, Christel Bonnas, Ulrich Dirnagl
  • Anti-infective agents and/or immunomodulators used for preventive therapy following an acute cerebrovascular accident
    Publication number: 20050234089
    Abstract: The invention refers to agents for the preventive therapy after acute stroke, in particular having the aim to prevent infections after stroke. The agents inventively employed in pharmaceutical preparations are anti-infective agents and/or immunomodulating agents, e.g. cytokines and/or inhibitors of the SNS.
    Type: Application
    Filed: March 5, 2003
    Publication date: October 20, 2005
    Inventors: Andreas Meisel, Konstantin Prass, Christian Meisel, Elke Halle, Ulrich Dirnagl, Hans Volk